[1]
Sallam, Y.A. et al. 2025. Circulating Tumor DNA: A Biomarker for Adjuvant Treatment Response in Stage III Colon Cancer. Journal of Neonatal Surgery. 14, 32S (Jul. 2025), 3641–3648.